NIIC Spirit of Life

View Auction Items

CLICK HERE

View Online Journal

CLICK HERE

2023 Spirit of Life Honoree

Sponsorships & Tickets

Donate Now

Help our cause by contributing to our fundraising efforts.

No act of generosity is too small to make a difference.

$100

$250

$500

$1,000

$2,500

Donor & Payment Information

Already have an account? Sign in

Email required

Select from the payment options below:

Terms and Conditions required

I have read and agree to the Terms and Conditions and Privacy Policy and give my consent to City of Hope to process my personal data. I understand I can revoke this consent at any time.

Donor approves the payments of any charitable donations and/or purchases to City of Hope in the amount set forth therein.

Subtotal:

Total:

Your credit card statement will reflect charges from ‘City of Hope’

Cancel

About City of Hope

City of Hope's mission is to deliver the cures of tomorrow to the people who need them today. Founded in 1913, City of Hope has grown into one of the largest cancer research and treatment organizations in the U.S. and one of the leading research centers for diabetes and other life-threatening illnesses. City of Hope research has been the basis for numerous breakthrough cancer medicines, as well as human synthetic insulin and monoclonal antibodies. With an independent, National Cancer Institute-designated comprehensive cancer center at its core, City of Hope brings a uniquely integrated model to patients spanning cancer care, research and development, academics and training, and innovation initiatives. City of Hope's growing national system includes its Los Angeles campus, a network of clinical care locations across Southern California, a new cancer center in Orange County, California, and treatment facilities in Atlanta, Chicago and Phoenix. City of Hope's affiliated family of organizations includes Translational Genomics Research Institute and AccessHope. For more information about City of Hope, follow us on Facebook, Twitter, YouTube, Instagram and LinkedIn.